康美药业：第十届监事会2025年度第二次会议决议公告

Group 1 - The core viewpoint of the article is that Kangmei Pharmaceutical announced the approval of its 2025 semi-annual report and summary by the 10th Supervisory Board during its second meeting [2] Group 2 - The announcement was made on the evening of August 29 [2] - The report pertains to the company's performance for the first half of 2025 [2] - The meeting was specifically focused on reviewing the semi-annual report [2]